Suzhou Novoprotein Lists on Shanghai’s STAR Market for R&D Expansion
Suzhou Novoprotein Scientific Co., Ltd, a China-based provider of protein technology and application solutions, has...
Deals
NeuShen Therapeutics Closes $20M Series Pre-A Financing for CNS Drug Development
NeuShen Therapeutics has announced the successful closure of a $20 million Series pre-A financing round...
3D Medicines Partners with Denfo Medical for Cancer Therapy Development
China-based 3D Medicines has entered into a strategic partnership with compatriot firm Denfo Medical Group,...
Simcere Grants Almirall Global Rights to Autoimmune Drug SIM0278
China’s Jiangsu Simcere Pharmaceutical Co., Ltd (HKG: 2096) has entered into a licensing agreement with...
Insight Lifetech Raises Funds for Cardiovascular Solutions Expansion
Insight Lifetech Co., Ltd, a Shenzhen-based provider of cardiovascular precision intervention solutions, has reportedly secured...
Eureka Biotech Partners with Ucello for Universal CAR-T Cell Therapy Development
Shenzhen Eureka Biotechnology Co., Limited, a China-based biotech firm, has entered into a partnership with...
Merck Sharp & Dohme Partners with Sinopharm for Molnupiravir in China
US-based Merck Sharp & Dohme (MSD, NYSE: MRK) has entered into a cooperation framework agreement...
Zai Lab Licenses Seagen’s Tivdak for Greater China Development and Commercialization
Chinese firm Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) has formed a collaboration with US-based...
Luye Pharma Grants ICI Pakistan Distribution Rights for Schizophrenia Drug Seroquel
China-based Luye Pharma Group has reportedly handed over the distribution and marketing rights for its...
Gluetacs Therapeutics Files IND for Molecular Glue Degrading Agent in China
Gluetacs Therapeutics has reported filing an Investigational New Drug (IND) application for its first molecular...
Hansoh Pharmaceutical Licenses KiOmedine One for Osteoarthritis Treatment
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced a licensing agreement with Belgium’s...
Ubrigene Raises Hundreds of Millions in Series C Financing Round
Yiming (Beijing) Cell Biotechnology Co., Ltd, also known as Ubrigene, a gene and cell therapy...
Sciwind Biosciences Partners with SynerK for siRNA Therapeutics Development
Hangzhou Sciwind Biosciences Co., Ltd has announced a research partnership with SynerK Inc. The collaboration...
Synthgene Partners with Micor&Nano for Comprehensive Solutions in Nucleic Acid Drugs
China-based Jiangsu Synthgene Biotechnology Co., Ltd has entered into a partnership with compatriot firm Micor&Nano...
ThunderBio Secures Funding from Guangzhou LBP for PCR Innovation
ThunderBio Innovation Limited, a specialist in droplet microfluidics and molecular diagnostics based in Zhejiang, has...
Shuangcheng Pharma Licenses US Rights for Paclitaxel Injection to Meitheal
China’s Hainan Shuangcheng Pharmaceutical Co., Ltd (SHA: 002693) has announced a licensing and supply agreement...
Nerviano Medical Sciences Collaborates with Merck on PARP1 Inhibitor NMS-293
Italy-based Nerviano Medical Sciences S.r.l. (NMS), which is 90% owned by Chinese investment fund SARI...
Sino Biopharmaceutical Licenses Lanifibranor for NASH Treatment from Inventiva
China-based Sino Biopharmaceutical Ltd (HKG: 1177) has announced that its subsidiary, Jiangsu Chia Tai Tianqing...
Menarini and OrigiMed Partner on Pan-Cancer Single-Cell Diagnostic Platform
Italy’s Menarini Group has formed a strategic partnership with China-based precision medicine firm OrigiMed to...
Jenscare Scientific Set for IPO to Fund Structural Heart Disease Solutions
Jenscare Scientific Co., Ltd., a structural heart disease intervention device maker based in Ningbo, is...